Nasogastric and intravenous erythromycin as prokinetic in intensive care patients: a randomized controlled study

ISRCTN	ISRCTN61956055
DOI	https://doi.org/10.1186/ISRCTN61956055
Protocol serial number	N0259108904
Sponsor	Department of Health (UK)
Funder	The Walton Centre for Neurology and Neurosurgery NHS Trust (UK)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr A Guha
Scientific

The Walton Centre for Neurology & Neurosurgery
Lower Lane
Fazakerley
Liverpool
L9 7LJ
United Kingdom

Phone	+44 (0)151 529 5772

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Erythromycin's effect on gastric emptying in intensive care.
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Signs and Symptoms:
Intervention	Nasogastric erythromycin compared to intravenous erythromycin
Intervention type	Other
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	01/07/2004

Participant type(s)	Patient
Age group	Adult
Sex	Not Specified
Target sample size at registration	20
Key inclusion criteria	Patients who exhibit a failure to absorb nasogastric feed
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/01/2002
Date of final enrolment	01/07/2004

The Walton Centre for Neurology & Neurosurgery

Liverpool
L9 7LJ
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan